Unichem Laboratories share news and announcements
NSE: UNICHEMLABBSE: 506690Pharmaceuticals & BiotechnologySmall Cap
Last close ₹472.95down ₹14.80 (3.03%)BSE ₹471.95
Share price at the NSE close on 23 Oct 2026. Previous close ₹487.75.
52-week range of traded prices to 23 Oct 2026
₹278.20Low, 30 Mar 2026₹687.20High, 9 Jul 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹3,330 Cr1,036th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 11 Aug 2026
- 10.9
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹205 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 33.3
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 22 May 2026
- 1.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 11 Aug 2026
- 11.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹205 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 3.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 11 Aug 2026
- 3.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 22 May 2026
- 0.17
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 40,08440.7% delivered
Unichem Laboratories share news and announcements
717 announcements, routine notices left out, newest first. Page 14 of 15.
Apr 2010
9 Apr · Results
Unichem Laboratories Ltd had informed the Exchange regarding publication of audited annual financial results for the year 2009-10. The Company has now informed the Exchange that the Company would be publishing un-audited financial results for the quarter ended March 31, 2010 within 45 days of the quarter end instead of publication of audited annual financial results.
Mar 2010
31 Mar · Results
As the Company proposes to announce the Audited Financial Results for the financial year ended March 31, 2010 as required under Clause 41 of the Listing Agreement, the Un-audited Financial Results for the last quarter ended March 31, 2010 will not be published.3 Mar · Updates
Company has received EU GMP certificate from IRISH MEDICINES BOARD for the 12 API's manufactured at Roha plant. With this approval the Company can market its approved API's in the whole of Europe. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2010
19 Feb · Updates
We have been granted Certificate of suitability to European Pharmacopeia (CEP) by European Directorate for the Quality of Medicines and Healthcare (EDQM) for Zolpidem Tartrate19 Feb · Updates
We have been granted Certificate of suitability to European Pharmacopeia (CEP) by European Directorate for the Quality of Medicines and Healthcare (EDQM) for Meloxicam4 Feb · Updates
Their Ghaziabad Formulation facility has been recertified by Medicines & Healthcare Products Regulatory Agencies (MHRA), U.K. The facility is recertified for both Medicines for Human as well as Veterinary use.
Jan 2010
20 Jan · Updates
Company has received approval from US Food & Drug Administration (U.S. FDA) for Hydrochlorothiazide Capsules in the strengths of 12.5 mg.19 Jan · Employee Stock Option Scheme
Board of Directors of the Company has in its meeting held on January 19, 2010, allotted and issued 1,900 equity shares of Rs. 5/- each pursuant to the exercise of the stock options by the eligible employees under the Employee Stock Option Scheme - 2004 of the Company.4 Jan · Board meeting
Meeting on 19 Jan 2010: “Unaudited Financial Results for the qtr ended Dec 31, 2009”
Dec 2009
4 Dec · Business
Press release dated December 4, 2009, titled " NICHE GENERICS LIMITED, the wholly owned subsidiary of Unichem Laboratories receives Marketing Authorizations for 'Anastrozole' ". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Nov 2009
9 Nov · Updates
The Company has received approval for its bulk drug (API) facility situated at Pithampur from US FDA. With this approval, both bulk drug facilities situated at Roha, Maharashtra and Pithampur, Madhya Pradesh are duly approved by US FDA. The Company's formulation facilities at Goa and Ghaziabad are already approved by US FDA
Oct 2009
22 Oct · Dividend
Board of Directors of the Company at its meeting held on October 22, 2009 declared an Interim Dividend of Rs.3/- (60%) per equity share of Rs.5/- for the year 2009-10.16 Oct · Meeting
Proceedings of the Annual General Meeting of the Company held on July 22, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.7 Oct · Board meeting
Meeting on 22 Oct 2009: “Unaudited Financial Results for the Qtr ended Sept 30, 2009/Unaudited Financial Results/dividend/Record date/others”
Aug 2009
28 Aug · Business
Press release dated August 27, 2009, titled "Unichem Laboratories receives ANDA approval from USFDA for CLONIDINE HYDROCHLORIDE TABLETS". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.20 Aug · Updates
Unichem laboratories Limited has received ANDA approval from the United States Food and Drug Adminstration (U.S. FDA) for Bisoprolol Fumarate Tablets USP, in the strengths of 5mg and 10mg
Jul 2009
28 Jul · Meeting
Members of the Company at its Annual General Meeting held on July 22, 2009, inter alia, have considered and approved the following : 1) Adoption of audited financial statements for the year ended March 31, 2009. 2) Confirmation of Interim Dividend of Rs. 3/- per equity share of Rs. 5/- each already paid for the year ended March 31, 2009. 3) Declaration of Final Dividend of Rs. 5/- per equity of Rs. 5/- each for the year ended March 31, 2009. 4) Re-appointment of Mr. Ramdas Gandhi as Director liable to retire by rotation. 5) Re-appointment of Mr. Nasser Munjee as Director liable to retire by rotation. 6) Re-appointment of M/s. B D Jokhakar & Co. as Statutory Auditors for the financial year 2009-10. 7) Appointment of Ms. Supriya Mody u/s 314(1B).16 Jul · Board meeting
Meeting on 22 Jul 2009: “Unaudited Financial Results for the Qtr ended June 30, 2009”
Jun 2009
26 Jun · Disclosure
As required under the Securities and Exchange Board of India (Employee Stock Option Scheme and Employee Stock Purchase Scheme) Guidelines, 1999, we hereby inform you that the Board of Directors of our Company has in its meeting held on June 25, 2009, allotted and issued 4500 equity shares of Rs.5 each pursuant to the exercise of the stock options by the eligible employee under the Employee Stock Option Scheme -2004 of the Company.18 Jun · Grant of Stock Options
As required under the Securities and Exchange Board of India (Employee Stock Option Scheme and Employee Stock Purchase scheme) Guidelines, 1999, we hereby inform you that the Compensation Committee of the Board of Directors of our Company has in its meeting held on June 17, 2009, granted 300,000 (Three Lacs) equity shares to the employees of the Company in terms of its Employee Stock Option Scheme - 2008. Against each option, the grantee will have a right to apply for and get allotted one equity share at an exercise price of Rs. 115/- (Rupees One Hundred and Fifteen only). The vesting period for the said options is in a graded manner over five years as prescribed in the Scheme.
May 2009
22 May · Board meeting
As required under the Securities and Exchange Board of India (Employee Stock Option Scheme and Employee Stock Purchase Scheme) Guidelines, 1999, we hereby inform you that the Board of Directors of our Company has in its meeting held on May 21, 2009, allotted and issued 1,700 equity shares of Rs.5/- each pursuant to the exercise of the stock options by the eligible employees under the Employee Stock Option Scheme - 2004 of the Company21 May · Meeting
Board of Directors in its meeting held on May 21, 2009 considered the following : (1) Recommended Final Dividend of Rs 5/- (100 %) per equity share of Rs 5/- each for the year ended March 31, 2009 (2) Decided to convene the Annual General Meeting of the Company on July 22, 2009. (3) Decided to close the Register of Members and Share transfer Books of the Company from July 13, 2009 to July 17, 2009 (both days inclusive), for the purpose of Annual General Meeting.14 May · Board meeting
Inter alia, to consider and take on record the Financial results of the Company for the Quarter ended March 31, 2009 and Audited Accounts for the year ended March 31, 2009 and to recommend Final Dividend on equity shares for the Financial Year 2008-2009.
Apr 2009
8 Apr · Management
Mr. B K Sharma's term of appointment as Whole-time Director has ended on 31st March 2009 and he has expressed his unwillingness to opt for re-appointment. Consequently, he communicated his decision to step down as Director from the Board of Unichem. Mr. Sharma was associated with the Company for nearly 4 decades. The Board has placed its appreciation for his contribution over the years
Mar 2009
30 Mar · Grant of Stock Options
As required under the Securities and Exchange Board of India (Employee Stock Option Scheme and Employee Stock Purchase scheme) Guidelines, 1999, we hereby inform you that the Compensation Committee of the Board of Directors of our Company has in its meeting held on March 26, 2009, granted 50,000 (Fifty Thousand) equity shares to independent Directors of the Company in terms of its Employee Stock Option Scheme - 2008. Against each option, the grantee will have a right to apply for and get allotted one equity share at an exercise price of Rs. 115/- (Rupees One Hundred and Fifteen only). The vesting period for the said options is in a graded manner over five years as prescribed in the Scheme.30 Mar · Updates
Unichem has received approval from US Food & Drug Administration (FDA) for Topiramate tablets in the strengths of 25mg, 50mg and 100 mg.30 Mar · Results
As the Company proposes to announce the Audited Financial Results for the financial year ended March 31, 2009 as required under Clause 41 of the Listing Agreement, the un-audited financial results for the last quarter ended March 31, 2009 will not be published.30 Mar · Management
Mr. Harcharan Singh has been appointed as Chief Executive - Pharma with effect March 24, 2009. He shall report to the Board of Directors.30 Mar · Allotment of Equity Shares
The Board of Directors of our Company has in its meeting held on March 26, 2009, allotted and issued 4,000 equity shares of Rs. 5/- each pursuant to the exercise of the stock options by the eligible employees under the Employee Stock Option Scheme - 2004 of the Company
Jan 2009
28 Jan · Issue and allotment of shares
Unichem Laboratories Ltd had informed the Exchange that : "The Board of Directors of our Company has in its meeting held on January 22, 2009, allotted and issued 5400 equity shares of Rs. 5/- each pursuant to the exercise of the stock options by the eligible employees / legal heirs under the Employee Stock Option Scheme - 2004 of the Company". The Company has now informed the Exchange that "The Board of Directors of our Company had in its meeting held on January 22, 2009, allotted and issued 6100 equity shares instead of Rs. 5400 equity shares of Rs.5/- each as inadvertently mentioned".22 Jan · Issue and allotment of shares
The Board of Directors of our Company has in its meeting held on January 22, 2009, allotted and issued 5400 equity shares of Rs. 5/- each pursuant to the exercise of the stock options by the eligible employees / legal heirs under the Employee Stock Option Scheme - 2004 of the Company13 Jan · Board meeting
Meeting on 22 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”
Dec 2008
3 Dec · Results
On the basis of the report submitted by Ms. Ragini Chokshi, the Scrutinizer, the Chairman has declared the Result of the Postal Ballot on November 28, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Nov 2008
10 Nov · Updates
Notice of the Completion of the Dispatch of the Postal Ballot Forms. The said notice was published in the newspapers on October 25, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2008
29 Oct · Meeting
Pursuant To Section 192A of the Companies Act, 1956 Read with the Companies (Passing of the Resolutions By Postal Ballot) Rules, 2001. The following Special Resolutions are proposed to be passed by means of postal ballot: (1) Special Resolution under Section 81(1A) of the Companies Act, 1956 for approval of ESOS- 2008 and issue of equity shares under the same to Employees and Directors including independent Director(s) of the Company. (2) Special Resolution under Section 81(1A) of the Companies Act, 1956 for issue of equity shares under the aforesaid ESOS- 2008 to Employees and Directors of the Subsidiaries of the Company. The Board has appointed Mrs. Ragini Chokshi, a Practicing Company Secretary as the Scrutinizer for conducting the Postal Ballot process. The Duy completed and signed Postal Ballot Form should reach the Scrutinizer not later than the close of the working hours on November 24, 2008. The Scrutinizer upon finalization of the poll results, will forward all ballot papers and registers for the approval of the Chairman. The results will be announced on November 28, 2008. A copy of the postal ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.23 Oct · Dividend
Board of Directors of the Company at its meeting held on October 23, 2008 declared an Interim Dividend of Rs.3/- (60%) per equity share of Rs.5/- for the year 2008-2009.16 Oct · Corporate action
Company has fixed October 31, 2008 as Record Date for the purpose of payment of Interim Dividend. Further the date of payment of Interim dividend is November 07, 2008.10 Oct · Board meeting
Inter-alia, to consider and take on record the Un-audited Financial Results of the Company for the Quarter ended September 30, 2008 and to consider declaration of Interim Dividend on equity shares for the year 2008-2009.10 Oct · Disclosure
The Board of Directors approved the Employees Stock Option Plan- 2008 and the Scheme thereunder. The Consent of the Members of the Company for approval of the same shall be sought by passing a Special Resolution by Postal Ballot
Aug 2008
19 Aug · Updates
Unichem has received approval from US Food & Drug Administration (FDA) for Hydrochlorothiazide tablets in the strengths of 25 mg and 50 mg14 Aug · Meeting
Proceedings of the Annual General Meeting of the Company held on July 17, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2008
17 Jul · Issue and allotment of shares
The Board of Directors of our Company has in its meeting held on July 17, 2008, allotted and issued 1,800 equity shares of Rs. 5/- each pursuant to the exercise of the stock options by the eligible employees/ legal heirs under the Employee Stock Option Scheme - 2004 of the Company4 Jul · Board meeting
Meeting on 17 Jul 2008: “Unaudited Financial Results for the Qtr ended June 30, 2008”
Jun 2008
23 Jun · Updates
Unichem has received US FDA approval for its Formulations plant situated at Ghaziabad, Uttar Pradesh. The said plant was upgraded in 2003 in order to meet the International Standards for manufacturing pharmaceutical products13 Jun · Updates
Unichem has received certificate from European Directorate for the Quality of Medicines and Healthcare for its Active Substances plant situated at Roha, Maharashtra. The EU GMP approval granted includes products like Hydrochlorothiazide, Metronidazole, Bendroflumethiazide,Amlodipine besilate,Flutamide.11 Jun · Updates
Unichem has received final approval from US Food & Drug Administration (FDA) for Zaleplon Capsules in the strengths of 5 mg and 10 mg. Zaleplon is indicated for the short - term treatment of insomia. Zaleplon capsules are generic equivalent of Kings Pharmaceuticals' Sonata Capsules. Unichem received the approval immediately on expiry of the patent on Zaleplon. The Company intends to launch the product in US Market shortly.
May 2008
12 May · Issue and allotment of shares
The Board of Directors of our Company has in its meeting held on May 12, 2008, allotted and issued 400 equity shares of Rs. 5/- each pursuant to the exercise of the stock options by the eligible employees/legal heirs under the Employee Stock Option Scheme - 2004 of the Company.12 May · Meeting
Board of Directors in their meeting held on May 12, 2008 considered the following : (1) Decided to convene the Annual General Meeting of the Company on July 17, 2008. (2) Decided to close the Register of Members and Share Transfer Books of the Company from July 14, 2008 to July 17, 2008 (both days inclusive) for the purpose of Annual General Meeting.12 May · Dividend
Board of Directors of the Company at its meeting held on May 12, 2008 has recommended dividend of Rs.5/- (100%) per equity share of Rs.5/- each, for the year ended March 31, 2008.2 May · Board meeting
Inter-alia, to consider and take on record the Financial Results of the Company for the Quarter ended March 31, 2008 and Audited Accounts for the year ended March 31, 2008 and to recommend a Dividend on equity shares for the Financial Year 2007-2008, if any.